<DOC>
	<DOC>NCT02900196</DOC>
	<brief_summary>The purpose of this clinical study is to evaluate the effect of a four-week consumption of a fresh fermented dairy drink containing probiotic strains on Antibiotic-Associated Diarrhea and Gastro-Intestinal disorders in adult subjects treated for Helicobacter pylori eradication.</brief_summary>
	<brief_title>Effect of a Fresh Fermented Dairy Drink Product Consumption on Antibiotic Associated Diarrhea and Gastro-Intestinal Disorders</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<criteria>Subjects who have read and signed the Study Informed Consent Form Subjects positive for Helicobacter pylori infection and symptomatic due to Helicobacter pylori infection Subjects with an indication, as stated by a Gastroenterologist, for the eradication of Helicobacter pylori Female subjects with a positive pregnancy test (based on serum test), or planning to become pregnant during the study or breastfeeding women Subjects enrolled in another interventional clinical study in the last 4 weeks or in an exclusion period following participation in another clinical trial Subject who have a history of alcohol abuse Subjects having diarrhea within the preceding 4weeks Subjects with severe lifethreatening illness, severe evolutive or chronic pathology Immunesuppressed subjects Subjects with benign peptic ulcer or premalignant or malignant lesion Subjects presenting with an infection of the gastrointestinal tract Subjects with any past severe gastrointestinal or metabolic pathology Subjects with history of Helicobacter pylori eradication therapy Subjects with history of cardiac or renal clinically significant disease Subjects that have had any surgery or intervention requiring general anesthesia in the last 4 weeks, or that have any planned Subjects with allergy or hypersensitivity against the medication for the eradication of Helicobacter pylori Subjects taking treatments likely to interfere with the evaluation of study parameters. Subjects with allergy or hypersensitivity to any component of the study products</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Probiotics</keyword>
	<keyword>Antibiotic Associated Diarrhea</keyword>
	<keyword>Gastro-Intestinal disorders</keyword>
	<keyword>Helicobacter pylori</keyword>
</DOC>